Navigation Links
NUCRYST and Smith & Nephew Revise Agreements
Date:10/1/2007

ing and obtain new regulatory approvals for any future products we may develop; we may not be able to establish successful commercialization programs, through new corporate collaborations or otherwise, for our future products; competition from other silver-based pharmaceutical or medical device companies; our ability to raise additional financing required to fund further research and development, clinical studies and obtain regulatory approvals, on commercially acceptable terms or at all; changes in currency exchange rates; our ability to protect our intellectual property rights and to not infringe on the intellectual property rights of others; our ability to comply with governmental regulations and standards; our ability to successfully attract and retain skilled and experienced personnel; changes in general economic and capital market conditions; other risks and uncertainties unidentified at this time; and management's response to these factors.

Although we have attempted to identify the important risks, uncertainties and other factors that could cause actual results or events to differ materially from those expressed or implied in forward-looking statements, there may be other factors that cause actual results or events to differ from those expressed or implied in forward looking statements. For a more thorough discussion of the risks associated with our business, see the "Risk Factors" section in our Annual Report on Form 10-K for the year ended December 31, 2006, filed with the U.S. Securities and Exchange Commission on EDGAR at http://www.sec.gov and with securities authorities in Canada on SEDAR at http://www.sedar.com. All forward-looking statements are expressly qualified in their entirety by this cautionary statement and NUCRYST disclaims any intention or obligation to revise or update any forward-looking statements whether as a result of new information,
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. Iodex goes to SmithKline Beecham consumer Healthcare
3. GlaxoSmithKline To Cultivate Non-Smoking Environment
4. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
5. FDA Mislead On Asthma Drug By GlaxoSmithKline
6. GlaxoSmithKline Defends Its Products
7. GlaxoSmithKline launches diabetes and cancer drugs
8. Generic Products Compete With GlaxoSmithKline
9. New Cervical Cancer Vaccine to Be Launched By Glaxo Smithkline
10. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
11. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 In today's healthcare landscape, ... it can be challenging for doctors and hospitals to ... treatments. , Austin-based HealthTronics, Inc. is ... mobile medical therapies for clinically sophisticated applications. The company ... acquisition of Laser Ventures, Inc ., a mobile ...
(Date:5/27/2015)... 2015 Dr. Omar Ibrahimi, Dermatologist and ... CT has been selected as part of a controlled ... (and the only physician in Connecticut) to offer the ... the removal of submental fat (double chin). The procedure ... no surgery and minimal risks. Dr. Ibrahimi is an ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a leading ... announced today that SanMar Corporation successfully implemented the ... and point tracking processes for over 3,000 employees ... , Family-owned since 1971, Seattle-based SanMar Corporation is ... and mill brands. SanMar supplies apparel and accessories ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 In support ... April 2015 issue of the Journal of American Geriatrics ... and abdominal obesity, Bedford Commons OB-GYN P.A . ... of non-nutritive sweetener-flavored beverages. , To examine the ... a comprehensive San Antonio Longitudinal Study of Aging (SALSA) ...
(Date:5/27/2015)... AR (PRWEB) May 27, 2015 ... today announce a partnership to provide CMSA's Career ... community. This collaboration seeks to strengthen the case/care ... through CMSA’s CKP program. The mutually beneficial agreement ... identifying individual skills of talent in the healthcare, ...
Breaking Medicine News(10 mins):Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3
... tea extract has recently achieved GRAS (Generally Recognized As ... US a strong signal of the ingredient’s suitability in ... being used in a number of supplement products in ... Vitamin Shoppe and Healthy Origins, American food companies say ...
... that postmenopausal women would have lesser chance of losing their ... Their research was published in the latest issue of Journal ... had found that in an average of 11 years, at ... says that alveolar bone loss is one of the most ...
... South Wales may be one of the first scientists to ... there is no single test that could exactly identify the ... the latest issue of the journal Psychiatry Research said that ... cost effective as their tool can safely distinguish between the ...
... to be in slumber for the past 11 months, baffling doctors ... Arup Manna of Panskura in East Midnapore district was an active ... suddenly started falling asleep., ,The meritorious boy, who used to ... for feeding and answering nature's call., ,The boy's mother says ...
... of morbidity and mortality in India. An attempt to formulate// ... many young lives, is worth the expense., , India ... a new vaccine for a deadly form of diarrhoea that ... been accelerated after phase I clinical trials showed up to ...
... soy Z-Trim fat replacer at a recent show //in New ... a variety of products without altering the food's original taste. ... soy Z-Trim fat replacer at a recent show in New ... 55 symposia and 14,000 attendees. , ,According to the ...
Cached Medicine News:Health News:Yet Another Use For Green Tea Extract 2Health News:New Insight In Periodontal Disease In Postmenopausal Women 2Health News:Schizophrenia Gets A New Diagnostic Tool 2Health News:New Oat And Soy-Based Fat Replacer Launched 2
(Date:5/27/2015)... -- Actavis plc (NYSE: ACT ) announced today ... and Drug Administration (FDA) as a twice-daily, oral ... with diarrhea (IBS-D). VIBERZI (eluxadoline) has mixed opioid ... a delta receptor antagonist, and a kappa receptor ... "The FDA,s approval of VIBERZI is ...
(Date:5/27/2015)... Madison Laser Tattoo Removal is the first laser tattoo ... the surrounding area to offer treatments with the Astanza Duality. ... dedicated to bringing a solution to those living with tattoo ... "I founded Madison Laser Tattoo Removal to give patients a ... its natural look," said Emily Livesey, RN and ...
(Date:5/27/2015)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life sciences ... of innovative products and services, today announced that its ... operations in Grand Rapids, Michigan ... , North Carolina.  Sequenom Laboratories, cystic fibrosis carrier screen ... North Carolina laboratory location.  "The ...
Breaking Medicine Technology:Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 2Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 3Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 4Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 5Madison Laser Tattoo Removal Brings Superior Laser Tattoo Removal Services To Madison, WI With Astanza Duality 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3
... , , SAN FRANCISCO , Feb. ... Board: MZEI) announced today that every full scale test ... has resulted in the total elimination of all bacteria present ... Medizone,s scientific team will attempt to confirm, in a more ...
... NEW YORK , Feb. 4 Delcath Systems, Inc. ... treatment system for metastatic cancers to the liver, announced today that ... on its Phase III trial.  The trial uses the drug melphalan ... "We remain very optimistic that the Phase III trial will achieve ...
Cached Medicine Technology:AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs 2AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs 3Delcath Systems Begins Data Analysis of Phase III Trial 2Delcath Systems Begins Data Analysis of Phase III Trial 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: